1、高度血管选择性CCB 更适合高血压合并心血管疾病患者 广州医学院第一附属医院心内科 何兆初Ljung B.Vascular selectivity of felodipine.Drugs 19851.Lancet 2019;364:84957./2.Lancet 2000;356:36672.3.Journal of Hypertension 2019,23:21572172./4.Circulation.2019,92:1326Advances in treatment of hypertension.CHINA PRESCRIPTION DRUG.2019 No.1 P.32-34 收缩压
2、每降低收缩压每降低1012mmHg1012mmHg和和/或舒张压每降低或舒张压每降低56mmHg56mmHg脑卒中脑卒中风险风险减少减少3838冠心病冠心病减少减少1616总的总的主要主要心血管心血管事件事件减少减少2020Poole-Wilson PA,et al.Lancet 2019-08-31.Brown M J,et al.INSIGHT study.Lancet,2000.356:366-372 Furberger CD,Psaty BM,et al.J.Circulation,2019,92(5):1326-1331 Lisheng Liu,et al.FEVER study.2
3、019为什么不同CCB循证医学的结果不同？Packer M.Circulation,1989,80(6):59 Koolen JJ,van Wezel HB,Pick J,et al.Am J Cardiol,1994,74:730-32 Koolen JJ,van Wezel HB,Pick J,et al.Am J Cardiol,1994,74:730-32 高度血管选择性CCB在安全性上优于非高度血管选择性CCBRaymond J.Gibbons,MD;ACC/AHA 2019 Guideline Update for the Management of Patients With C
4、hronic Stable Angina;2019 by the American College of Cardiology Foundation and the American Heart Association,IncKarl Swedberg,et al;Guidelines for the diagnosis and treatment of chronic heart failure:full text(update 2019);European Heart Journal慢性稳定性心绞痛诊断与治疗指南慢性稳定性心绞痛诊断与治疗指南;中华医学会心血管病学分会中华医学会心血管病学分会 中华心血管病杂志编辑委员会中华心血管病杂志编辑委员会;2019-01-08;2019-01-082019ACC/AHA心衰指南风险患者定义心衰指南风险患者定义
